The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, is launching the John Crowley, PhD, Award, to encourage statistical excellence in clinical trials.
The FY20 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Ovarian Cancer Research Program to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.
The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program to support innovative, high-impact lung cancer research.
The Neuroendocrine Tumor Research Foundation provided $3.5 million in neuroendocrine tumor research grants to 12 projects to find more precise treatments for the cancer.
ALK Positive/LUNGevity is requesting applications for the 2020 ALK-positive Lung Cancer Research Award. Letters of intent are due Feb. 14.
The American Cancer Society and Flatiron Health launched a joint grant-making program that supports both organizations' goals of accelerating cancer research and improving treatment and care options for patients.
The Leukemia & Lymphoma Society announced that it has more than doubled its funding of research focused specifically on childhood blood cancers, adding 20 new research grants valued at more than $13.8 million to its research portfolio in 2019.
The Snowdome Foundation and Leukaemia Foundation joined with the Leukemia & Lymphoma Society to fund four blood cancer research projects with Australian researchers through the LLS Translational Research Program.
I have devoted my career to improving care for people living with cancer. It wasn't until my father was diagnosed with head and neck cancer that I realized just how complex navigating the cancer care experience can be—and how much I had to learn as a caregiver. To improve the lives of people living with cancer, we must focus on more than treatment and address care holistically.
The FY19 Defense Appropriation provides $10 million to the Department of Defense Melanoma Research Program to support innovative, high-impact melanoma research.
